TIVOZIB, created in 2011 (United States), from 13 sister brands. TIVOZIB is owned by Aveo Pharmaceuticals, listed on the stock exchange of New York The sector of TIVOZIB is Divers.
Share price brand.technical-problem
Yield (Dividend per share)
(2019-2023) Stoxx Europe 600 : +36.90 % S&P 500 NY : +84.20 %